Therefore, the possibility that NPAS-4 and NPTX-2 may serve as diagnostic and therapeutic biomarkers in Alzheimer’s disease warrants further investigation. The gene discussed is NPTX2; the disease is early-onset autosomal dominant Alzheimer disease.